Brief: Cannara Biotech Delivers Q4
Nov 24 (Reuters) - Cannara Biotech Inc LOVE.V: CANNARA BIOTECH DELIVERS RECORD FISCAL 2025 REVENUE AND PROFITABILITY, ACHIEVES FIRST YEAR OF POSITIVE RETAINED EARNINGS CANNARA BIOTECH Q4 EPS CAD 0.04 CANNARA BIOTECH Q4 REVENUE CAD 28.3 MILLION CANNARA BIOTECH Q4 NET INCOME CAD 3.3 MILLION Source text: ID:nGNX9c2MKC Further company coverage: LOVE.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsBrief: Cannara Biotech - Enters Amended Syndicated Credit Agreement With BMO And Td
Cannara Biotech Q3 revenue tops estimates on expanded distribution
Canada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4